
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
She was moments away from giving birth. The hospital discharged her - 2
Robert Pattinson claims he's a pathological liar. What 'The Drama' star has said about his 'shtick' - 3
Defeating An inability to embrace success in Scholarly world: Individual Victories - 4
Why the chemtrail conspiracy theory lingers and grows – and why Tucker Carlson is talking about it - 5
Monetary Versatility: Get ready for Life's Unforeseen Difficulties
Tata Motors, BMW among automakers set to raise prices in India
Exploring School Life: Self-awareness and Illustrations
Fiber is something most people could use more of. But experts advise caution with 'fibermaxxing'
How on earth did 'Shark Tank' star Kevin O'Leary end up in 'Marty Supreme'? I'll let him explain.
Study shows no clear link between low-fat dairy and dementia risk
Weeks-Long Australian LNG Outage Will Further Tighten Supply
Step by step instructions to Utilize Open Record Rewards for Your Potential benefit
Step by step instructions to Contrast Lab Precious stones and Normal Jewels
The Ascent of the Kona SUV: How Hyundai's Reduced Hybrid Is Vanquishing the Streets













